CBUS — Cibus Global LLC
NASDAQ · Healthcare · Biotechnology
$1.56
-$0.06 (-3.70%)
Cibus Global LLC (CBUS) is a biotechnology company listed on NASDAQ. It is led by Peter R. Beetham B.Sc., Ph.D., based in 6455 Nancy Ridge Drive, San Diego, CA, United States, 92121, with about 157 employees. Cibus, Inc., an agricultural biotechnology company, develops and licenses gene edited plant traits using gene editing technologies to enhance farming productivity or produce renewable low carbon plant products. It focuses on trait productivity in the productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients, which enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was founded in 2001 and is headquartered in San Diego, California.
Latest reported CBUS revenue for 2025-09-30 was $615.0K. Net income was -$24.3M. Revenue was down 34.1% from 2025-06-30 to 2025-09-30. CBUS currently screens at market cap $79.7M.
Use this CBUS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CBUS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CBUS SEC filings page. Lician reads the product cache first so this HTML stays unique to Cibus Global LLC even when a live quote feed is slow.
About Cibus Global LLC
Cibus, Inc., an agricultural biotechnology company, develops and licenses gene edited plant traits using gene editing technologies to enhance farming productivity or produce renewable low carbon plant products. It focuses on trait productivity in the productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients, which enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was founded in 2001 and is headquartered in San Diego, California.
CBUS Key Statistics
Market Cap
$79.66M
Volume
87,835
Previous Close
$1.68
Day Range
$1.66 – $1.75
EPS
-$10.83
Revenue
$4.26M
Net Income
-$282.71M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+134.6%
Profit Margin
-6633.3%
Employees
157
CBUS Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $4.26M | $1.82M | $157.00K | $25.99M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$282.71M | -$337.64M | -$16.89M | $29.20M |
| EPS (Diluted) | -$10.83 | -$25.95 | -$18.36 | -$0.78 |
Total Assets
$350.07M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$14.43M
Operating Cash Flow
-$58.04M
Free Cash Flow
$0.00
Cibus Global LLC Company Information
- Co-Founder, Interim CEO, President, COO & Director
- Peter R. Beetham B.Sc., Ph.D.
- Headquarters
- 6455 Nancy Ridge Drive, San Diego, CA, United States, 92121
- Website
- www.cibus.com
- Phone
- 858 450 0008
- IPO / Founded
- 2023-06-01
- Sector
- Healthcare
- Industry
- Biotechnology